| 注册
首页|期刊导航|临床与实验病理学杂志|EBV潜伏基因产物在恶性淋巴瘤组织中的表达及意义

EBV潜伏基因产物在恶性淋巴瘤组织中的表达及意义

张雅洁 王广才 张丽红 绵贯勤

临床与实验病理学杂志2001,Vol.17Issue(2):106-109,4.
临床与实验病理学杂志2001,Vol.17Issue(2):106-109,4.

EBV潜伏基因产物在恶性淋巴瘤组织中的表达及意义

Expression of EBV latent gene products and their significance in malignant lymphoma

张雅洁 1王广才 1张丽红 2绵贯勤3

作者信息

  • 1. 广州医学院病理学教研室
  • 2. 白求恩医科大学病理学教研室
  • 3. 日本秋田大学医学部第一病理教室
  • 折叠

摘要

Abstract

Purpose To study the expression and significance of EBV latent gene products in malignant lymphoma. Methods Immunohistochemical staining for LMP-1 and EBNA2 was performed in 565 cases of non-Hodgkins lymphoma(NHL) and 64 Hodgkins lymphoma(HL). EBV was also detected in 101 cases of NHL by PCR.Results EBV-PCR positive rate was higher than that of LMP-1. LMP-1 expression was not found in EBV-PCR negative NHL. No staining for EBNA2 was detected in our series. LMP-1 expression was found in immunoblast cells and R-S cells and R-S-like cells,which also expressed CD30. Conclusions Expression of EBV latent gene products can reflect the differential degree of host cells and ability of immune surveillance. EBV may be related to the development of some R-S cells and R-S-like cells in malignant lymphomas.

关键词

淋巴瘤/EB病毒/潜伏基因产物/免疫组织化学/聚合酶链反应

分类

医药卫生

引用本文复制引用

张雅洁,王广才,张丽红,绵贯勤..EBV潜伏基因产物在恶性淋巴瘤组织中的表达及意义[J].临床与实验病理学杂志,2001,17(2):106-109,4.

临床与实验病理学杂志

OACSCD

1001-7399

访问量2
|
下载量0
段落导航相关论文